Corpus Intelligence IC Memo — SEBASTIAN RIVER MEDICAL CENTER 2026-04-26 13:55 UTC
IC Memo — SEBASTIAN RIVER MEDICAL CENTER
Investment Committee Memorandum | FL | 145 beds | Grade C | EBITDA uplift $8.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SEBASTIAN RIVER MEDICAL CENTER

CCN 100217 | INDIAN RIVER, FL | 145 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SEBASTIAN RIVER MEDICAL CENTER is a 145-bed suburban community hospital in INDIAN RIVER, FL with $120.5M in net patient revenue and a 2.8% operating margin. The hospital serves a payer mix of 34.2% Medicare, 0.4% Medicaid, and 65.4% commercial.

Thesis: Undervalued. Our ML models identify $8.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.8% to 10.1% (+736bps).

Net Revenue HCRIS$120.5M
Current EBITDA COMPUTED$3.3M
Operating Margin COMPUTED2.8%
Occupancy HCRIS35.0%
Revenue / Bed COMPUTED$831K
Net-to-Gross HCRIS10.6%
Distress Probability ML49.5%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
129
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 2.8% places it below the state median. Among 129 size-comparable peers (72-290 beds), the median margin is 3.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (72-290), prioritizing same-state peers. 129 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SEBASTIAN RIVER MEDICAL CENTER (Target)FL145$120.5M2.8%
MOFFITT CANCER CENTERFL218$1.91B16.0%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
JOHNS HOPKINS ALL CHILDRENS HOFL259$584.5M-10.3%
HOLY CROSS HOSPITALFL286$566.3M-0.7%
CCF HOSPITAL - WESTONFL258$465.4M-3.8%
BAPTIST HOSPITALFL279$445.0M-26.4%
LARGO MEDICAL CENTERFL245$386.4M24.1%
CAPE CORAL HOSPITALFL289$382.1M35.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.5M+210bp18mo
Cost to Collect4.5%2.5%$2.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$77K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.5M
Cost to Collect
$2.4M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.5M
Clean Claim Rate
$77K
Total EBITDA Uplift$8.9M
Current EBITDA$3.3M
+ RCM Uplift+$8.9M
Pro Forma EBITDA$12.2M
Current Margin2.8%
Pro Forma Margin10.1%
WC Released (1x)$4.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$5.1M$110.8M21.55x84.8%
Base (11x exit)10.0x11.0x$5.1M$123.5M24.03x88.9%
Bull Case9.0x11.0x$4.6M$154.5M33.39x101.7%
Bull (12x exit)9.0x12.0x$4.6M$169.9M36.72x105.6%
Bear Case11.0x10.0x$5.7M$64.7M11.45x62.8%
Bear (11x exit)11.0x11.0x$5.7M$73.0M12.92x66.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 129 hospitals with 72-290 beds
  • Same-state prioritization (n=130)
  • Comp margins: P25=-5.4% / P50=3.9% / P75=15.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.